Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

May C Morris

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Biotechnology Journal|April 22, 2017
Targeting Conformational Activation of CDK2 KinaseMorgan Pellerano, Sergey Tcherniuk, Corine Perals, et al.
Small (Weinheim an Der Bergstrasse, Germany)|January 27, 2021
Nanobiosensor Reports on CDK1 Kinase Activity in Tumor Xenografts in MiceCarmen Mihaela Tîlmaciu, Bhimareddy Dinesh, Morgan Pellerano, et al.
Biophysical Journal|August 11, 2015
Conformational Equilibrium of CDK/Cyclin Complexes by Molecular Dynamics with Excited Normal ModesNicolas Floquet, Mauricio G S Costa, Paulo R Batista, et al.
Chembiochem : a European Journal of Chemical Biology|March 22, 2019
Microneedle Array-Based Platforms for Future Theranostic ApplicationsOlivia Howells, Natasha Rajendran, Sarah Mcintyre, et al.
Biochemistry|July 19, 2018
Rationally Designed Peptides as Efficient Inhibitors of Nucleic Acid Chaperone Activity of HIV-1 Nucleocapsid ProteinVolodymyr Shvadchak, Sarwat Zgheib, Beata Basta, et al.
Chembiochem : a European Journal of Chemical Biology|January 27, 2015
Tampering with cell division by using small-molecule inhibitors of CDK-CKS protein interactionsAmel Hamdi, Aurélien Lesnard, Peggy Suzanne, et al.
Theranostics|February 28, 2020
Stapled peptide targeting the CDK4/Cyclin D interface combined with Abemaciclib inhibits KRAS mutant lung cancer growthCeline Bouclier, Matthieu Simon, Guillaume Laconde, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 28, 2017
Rational Design of Nanobody80 Loop Peptidomimetics: Towards Biased β<sub>2</sub> Adrenergic Receptor LigandsCharlotte Martin, Samuel L C Moors, Mia Danielsen, et al.
Molecular Oncology|April 21, 2023
CDK6 is activated by the atypical cyclin I to promote E2F-mediated gene expression and cancer cell proliferationEva Quandt, Núria Masip, Sara Hernández-Ortega, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Biotechnology Journal|April 22, 2017
Targeting Conformational Activation of CDK2 KinaseMorgan Pellerano, Sergey Tcherniuk, Corine Perals, et al.
Small (Weinheim an Der Bergstrasse, Germany)|January 27, 2021
Nanobiosensor Reports on CDK1 Kinase Activity in Tumor Xenografts in MiceCarmen Mihaela Tîlmaciu, Bhimareddy Dinesh, Morgan Pellerano, et al.
Biophysical Journal|August 11, 2015
Conformational Equilibrium of CDK/Cyclin Complexes by Molecular Dynamics with Excited Normal ModesNicolas Floquet, Mauricio G S Costa, Paulo R Batista, et al.
Chembiochem : a European Journal of Chemical Biology|March 22, 2019
Microneedle Array-Based Platforms for Future Theranostic ApplicationsOlivia Howells, Natasha Rajendran, Sarah Mcintyre, et al.
Biochemistry|July 19, 2018
Rationally Designed Peptides as Efficient Inhibitors of Nucleic Acid Chaperone Activity of HIV-1 Nucleocapsid ProteinVolodymyr Shvadchak, Sarwat Zgheib, Beata Basta, et al.
Chembiochem : a European Journal of Chemical Biology|January 27, 2015
Tampering with cell division by using small-molecule inhibitors of CDK-CKS protein interactionsAmel Hamdi, Aurélien Lesnard, Peggy Suzanne, et al.
Theranostics|February 28, 2020
Stapled peptide targeting the CDK4/Cyclin D interface combined with Abemaciclib inhibits KRAS mutant lung cancer growthCeline Bouclier, Matthieu Simon, Guillaume Laconde, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 28, 2017
Rational Design of Nanobody80 Loop Peptidomimetics: Towards Biased β<sub>2</sub> Adrenergic Receptor LigandsCharlotte Martin, Samuel L C Moors, Mia Danielsen, et al.
Molecular Oncology|April 21, 2023
CDK6 is activated by the atypical cyclin I to promote E2F-mediated gene expression and cancer cell proliferationEva Quandt, Núria Masip, Sara Hernández-Ortega, et al.
Pageof 6